Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for DAWN
sharewise wants to provide you with the best news and tools for DAWN, so we directly link to the best financial data sources.
Financials
News
Day One (DAWN) Q2 Revenue Jumps 313%
Day One Biopharmaceuticals (NASDAQ:DAWN), a clinical-stage biopharmaceutical company focused on developing therapies for pediatric cancers and rare tumor types, reported its earnings for Q2 2025 on
